136 related articles for article (PubMed ID: 28783247)
1. Bacterial translocation and clinical progression of HCV-related cirrhosis in HIV-infected patients.
Merchante N; Aldámiz-Echevarría T; García-Álvarez M; Rivero-Juárez A; Macías J; Miralles P; Jiménez-Sousa MA; Mancebo M; Pérez-Latorre L; Pineda-Tenor D; Berenguer J; Resino S; Pineda JA
J Viral Hepat; 2018 Feb; 25(2):180-186. PubMed ID: 28783247
[TBL] [Abstract][Full Text] [Related]
2. Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis.
Merchante N; Rivero-Juárez A; Téllez F; Merino D; José Ríos-Villegas M; Márquez-Solero M; Omar M; Macías J; Camacho A; Pérez-Pérez M; Gómez-Mateos J; Rivero A; Antonio Pineda J;
Hepatology; 2012 Jul; 56(1):228-38. PubMed ID: 22278746
[TBL] [Abstract][Full Text] [Related]
3. Progression of liver stiffness predicts clinical events in HIV/HCV-coinfected patients with compensated cirrhosis.
Merchante N; Téllez F; Rivero-Juárez A; Ríos-Villegas MJ; Merino D; Márquez-Solero M; Omar M; Recio E; Pérez-Pérez M; Camacho Á; Macías-Dorado S; Macías J; Lorenzo-Moncada S; Rivero A; Pineda JA;
BMC Infect Dis; 2015 Dec; 15():557. PubMed ID: 26643257
[TBL] [Abstract][Full Text] [Related]
4. Bacterial translocation in HIV-infected patients with HCV cirrhosis: implication in hemodynamic alterations and mortality.
de Oca Arjona MM; Marquez M; Soto MJ; Rodriguez-Ramos C; Terron A; Vergara A; Arizcorreta A; Fernandez-Gutierrez C; Giron-González JA
J Acquir Immune Defic Syndr; 2011 Apr; 56(5):420-7. PubMed ID: 21266909
[TBL] [Abstract][Full Text] [Related]
5. Eradication of Hepatitis C Virus (HCV) Reduces Immune Activation, Microbial Translocation, and the HIV DNA Level in HIV/HCV-Coinfected Patients.
López-Cortés LF; Trujillo-Rodríguez M; Báez-Palomo A; Benmarzouk-Hidalgo OJ; Dominguez-Molina B; Milanés-Guisado Y; Espinosa N; Viciana P; Gutiérrez-Valencia A
J Infect Dis; 2018 Jul; 218(4):624-632. PubMed ID: 29986086
[TBL] [Abstract][Full Text] [Related]
6. Immune activation response in chronic HIV-infected patients: influence of Hepatitis C virus coinfection.
Márquez M; Romero-Cores P; Montes-Oca M; Martín-Aspas A; Soto-Cárdenas MJ; Guerrero F; Fernández-Gutiérrez C; Girón-González JA
PLoS One; 2015; 10(3):e0119568. PubMed ID: 25775475
[TBL] [Abstract][Full Text] [Related]
7. Haemodynamic derangement in human immunodeficiency virus-infected patients with hepatitis C virus-related cirrhosis: the role of bacterial translocation.
Montes-de-Oca M; Blanco MJ; Marquez M; Soto MJ; Fernandez-Gutiérrez C; Rodriguez-Ramos C; Giron-Gonzalez JA
Liver Int; 2011 Jul; 31(6):850-8. PubMed ID: 21645216
[TBL] [Abstract][Full Text] [Related]
8. Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection.
Sacchi P; Cima S; Corbella M; Comolli G; Chiesa A; Baldanti F; Klersy C; Novati S; Mulatto P; Mariconti M; Bazzocchi C; Puoti M; Pagani L; Filice G; Bruno R
Dig Liver Dis; 2015 Mar; 47(3):218-25. PubMed ID: 25544657
[TBL] [Abstract][Full Text] [Related]
9. Contribution of Liver Fibrosis and Microbial Translocation to Immune Activation in Persons Infected With HIV and/or Hepatitis C Virus.
Reid M; Ma Y; Scherzer R; Price JC; French AL; Huhn GD; Plankey MW; Peters M; Grunfeld C; Tien PC
J Infect Dis; 2018 Mar; 217(8):1289-1297. PubMed ID: 29304196
[TBL] [Abstract][Full Text] [Related]
10. HIV Infection, HCV Coinfection, and Alcohol Use: Associations with Microbial Translocation and Immune Activation.
Monnig MA; Cohen R; Ramratnam B; McAdams M; Tashima K; Monti PM
Alcohol Clin Exp Res; 2019 Jun; 43(6):1126-1134. PubMed ID: 30908642
[TBL] [Abstract][Full Text] [Related]
11. HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis.
Pineda JA; Romero-Gómez M; Díaz-García F; Girón-González JA; Montero JL; Torre-Cisneros J; Andrade RJ; González-Serrano M; Aguilar J; Aguilar-Guisado M; Navarro JM; Salmerón J; Caballero-Granado FJ; García-García JA; ;
Hepatology; 2005 Apr; 41(4):779-89. PubMed ID: 15800956
[TBL] [Abstract][Full Text] [Related]
12. Microbial translocation is correlated with HIV evolution in HIV-HCV co-infected patients.
Tudesq JJ; Dunyach-Remy C; Combescure C; Doncesco R; Laureillard D; Lavigne JP; Sotto A
PLoS One; 2017; 12(9):e0183372. PubMed ID: 28934209
[TBL] [Abstract][Full Text] [Related]
13. Microbial translocation and liver disease progression in women coinfected with HIV and hepatitis C virus.
French AL; Evans CT; Agniel DM; Cohen MH; Peters M; Landay AL; Desai SN
J Infect Dis; 2013 Aug; 208(4):679-89. PubMed ID: 23687224
[TBL] [Abstract][Full Text] [Related]
14. Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection.
Sandler NG; Koh C; Roque A; Eccleston JL; Siegel RB; Demino M; Kleiner DE; Deeks SG; Liang TJ; Heller T; Douek DC
Gastroenterology; 2011 Oct; 141(4):1220-30, 1230.e1-3. PubMed ID: 21726511
[TBL] [Abstract][Full Text] [Related]
15. Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1-infected individuals.
Abad-Fernández M; Vallejo A; Hernández-Novoa B; Díaz L; Gutiérrez C; Madrid N; Muñoz MA; Moreno S
J Acquir Immune Defic Syndr; 2013 Oct; 64(2):149-53. PubMed ID: 24047967
[TBL] [Abstract][Full Text] [Related]
16. During Hepatitis C Virus (HCV) Infection and HCV-HIV Coinfection, an Elevated Plasma Level of Autotaxin Is Associated With Lysophosphatidic Acid and Markers of Immune Activation That Normalize During Interferon-Free HCV Therapy.
Kostadinova L; Shive CL; Judge C; Zebrowski E; Compan A; Rife K; Hirsch A; Falck-Ytter Y; Schlatzer DM; Li X; Chance MR; Rodriguez B; Popkin DL; Anthony DD
J Infect Dis; 2016 Nov; 214(9):1438-1448. PubMed ID: 27540113
[TBL] [Abstract][Full Text] [Related]
17. Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy.
Pineda JA; García-García JA; Aguilar-Guisado M; Ríos-Villegas MJ; Ruiz-Morales J; Rivero A; del Valle J; Luque R; Rodríguez-Baño J; González-Serrano M; Camacho A; Macías J; Grilo I; Gómez-Mateos JM;
Hepatology; 2007 Sep; 46(3):622-30. PubMed ID: 17659577
[TBL] [Abstract][Full Text] [Related]
18. Role of microbial translocation in soluble CD14 up-regulation in HIV-, but not in HCV-, infected chimpanzees.
Verstrepen BE; Nieuwenhuis IG; Mooij P; Verschoor EJ; Fagrouch ZC; Kondova I; Boonstra A; Koopman G
J Gen Virol; 2016 Oct; 97(10):2599-2607. PubMed ID: 27534537
[TBL] [Abstract][Full Text] [Related]
19. Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus-coinfected patients with compensated cirrhosis.
Mira JA; Rivero-Juárez A; López-Cortés LF; Girón-González JA; Téllez F; de los Santos-Gil I; Macías J; Merino D; Márquez M; Ríos-Villegas MJ; Gea I; Merchante N; Rivero A; Torres-Cornejo A; Pineda JA;
Clin Infect Dis; 2013 Jun; 56(11):1646-53. PubMed ID: 23429381
[TBL] [Abstract][Full Text] [Related]
20. Effect of liver fibrosis on long-term mortality in HIV/hepatitis C virus-coinfected individuals who are evaluated to receive interferon therapies in the highly active antiretroviral therapy era.
Sanmartin R; de Felipe E; Tor J; Sanvicens A; Barluenga E; Martinez E; Muga R; Jou A; Ojanguren I; López JJ; Clotet B; Tural C
AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1235-43. PubMed ID: 22443303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
